Clinical study on the treatment of renal colic with Qiu acupoint acupressure, an appropriate technique of traditional Chinese medicine

Phase 1

Recruiting

• Conditions: Renal colic

• Registration Number: ITMCTR2100004931
• Lead Sponsor: The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1.Consistent with the following symptoms and signs:
(1) Sudden onset of abdominal pain and discomfort;
(2) When the attack physical examination of the affected side of the kidney area may have tenderness or percussion pain;
(3) The pain may be accompanied by pallor, weakness, nausea and vomiting, sweating, etc.;
(4) Digestive tract reaction (nausea and vomiting, dry mouth);
(5) Perineal radiating pain;
(6) Urinary irritation symptoms (frequency, urgency and pain);
(7) Anorectal stimulation (frequent bowel movement, tenesmus);
(8) Today hematuria (mirror or naked eyes), often after the activity;
Above symptom (1), (2)is necessary condition;
2. Exclude other symptoms of lumbago that are not caused by ureterospasm;
3. The patient is conscious and has stable vital signs, and can cooperate with the treatment;
4. Voluntarily participate in this clinical trial, give informed consent and sign informed consent;
5. The patient is between 18 and 65 years old.

Exclusion Criteria

1. Delirious, mentally ill, with other serious diseases, unable to cooperate with the treatment of the patient;
2. Women during pregnancy, pregnancy and lactation;
3. Local skin is broken or ulcerated;, with severe primary diseases of viscera and other systems, and with severe urinary tract infection in urgent need of anti-infection treatment;
4. Allergy to non-steroidal anti-inflammatory drugs, previous history of gastrointestinal bleeding or active gastric ulcer, and relevant contraindications prohibited in the drug instructions;
5. Oral history of taking calcium ion blocker and alpha blocker within 4 days before enrollment;
6. Patients with poor treatment compliance;
7. Previous patients with severe cardiovascular and cerebrovascular diseases.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Onset time of analgesia;

Secondary Outcome Measures

Name	Time	Method
VAS scores at 1, 5, 10, 20, 30 and 120min before and after treatment;Efficiency;The recurrence rate;